OCCURRENCE OF AUTOIMMUNE ANTIBODIES TO LIVER MICROSOMAL PROTEINS ASSOCIATED WITH LETHAL HEPATITIS IN LEC RATS - EFFECTS OF TJN-101 L-10,11-METHYLENEDIOXY-6-DIBENZO[A,C]CYCLOOCTENOL) ON THE DEVELOPMENT OF HEPATITIS AND THE AUTOANTIBODIES())
T. Yokoi et al., OCCURRENCE OF AUTOIMMUNE ANTIBODIES TO LIVER MICROSOMAL PROTEINS ASSOCIATED WITH LETHAL HEPATITIS IN LEC RATS - EFFECTS OF TJN-101 L-10,11-METHYLENEDIOXY-6-DIBENZO[A,C]CYCLOOCTENOL) ON THE DEVELOPMENT OF HEPATITIS AND THE AUTOANTIBODIES()), Toxicology letters, 76(1), 1995, pp. 33-38
Long Evans Cinnamon (LEG) rats, that spontaneously develop hepatitis,
were found to possess autoantibodies to liver microsomal proteins (ant
i-LM) before the development of hepatitis. Anti-LM antibody was assume
d to appear in association with the lethal hepatitis in the LEC rats.
Thus, the purpose of this study was to investigate the effects of an a
nti-hepatitis drug on the development of hepatitis and the occurrence
of the antibody in LEC rats. Mortality, blood biochemical parameters a
nd the titer of serum anti-LM antibody were measured. In control LEC r
ats, 4 of 8 rats died before 20 weeks of age. In rats treated with TJN
-101 -tetrahydro-1,2,3,12-tetramethoxy-6,7-dimethyl-10, 11-methylenedi
oxy-6-dibenzo[a, c]cyclooctenol), 4 of 7 rats died of hepatitis, but t
he time of death was delayed by 7-10 weeks compared to the control rat
s, The titer of the anti-LM antibody increased 3-7 weeks before death
in the non-survivors in control and TJN-101-treated rats, supporting t
he idea that anti-LM antibody occurs in association with acute lethal
hepatitis.